510(k) K984596
K984596 is an FDA 510(k) premarket notification submitted by Zymetx, Inc. for the device "VIRASTAT FITC-LABELED ANTI-INFLUENZA A AND B MONOCLONAL ANTIBODIES". The FDA issued a decision of Substantially Equivalent on March 4, 1999. The device falls under product code GNR (Antisera, Neutralization, Influenza Virus A, B, C), a Class I device regulated under 21 CFR 866.3330. Zymetx, Inc. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 4, 1999
- Date Received
- December 28, 1998
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antisera, Neutralization, Influenza Virus A, B, C
- Device Class
- Class I
- Regulation Number
- 866.3330
- Review Panel
- MI
- Submission Type